Form 4: Dolby SVP Sells 7,000 Shares Under 10b5-1 Plan
Insider Transaction Report
Dolby Laboratories' SVP of Advanced Technology Group, Shriram Revankar, reported the sale of 7,000 shares of Class A Common Stock for $74.92 per share, effective August 22, 2025.
Summary
- Shriram Revankar, the Senior Vice President of Advanced Technology Group at Dolby Laboratories, Inc. (DLB), reported an insider stock sale.
- The transaction involved the disposition of 7,000 shares of Dolby's Class A Common Stock.
- The shares were sold at a price of $74.92 per share.
- The transaction date for this sale was August 22, 2025.
- Following this transaction, Revankar will beneficially own 70,435 shares of Class A Common Stock.
- The remaining beneficial ownership includes 47,766 shares underlying restricted stock units (RSUs) which are subject to forfeiture until they vest.
- The transaction was executed pursuant to a Rule 10b5-1(c) plan, indicating a pre-scheduled sale.
Sentiment
Score: 5
Explanation: The filing reports an insider stock sale, which is typically viewed neutrally to slightly negatively. However, the transaction was executed under a Rule 10b5-1 plan, indicating a pre-scheduled sale rather than a discretionary one, which mitigates potential negative sentiment.
Positives
- The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-scheduled sale rather than a discretionary one based on new, non-public information.
- The sale occurred at a price of $74.92 per share.
Negatives
- An insider, Shriram Revankar, SVP of Advanced Technology Group, disposed of 7,000 shares of Class A Common Stock.
Future Outlook
NA
Industry Context
This filing is a routine insider transaction report and does not provide specific industry-wide context or trends. It reflects an individual executive's stock activity within Dolby Laboratories, Inc.
Stakeholder Impact
- Shareholders: May view the insider sale as a data point for their investment decisions, though the pre-arranged 10b5-1 plan mitigates the perception of a discretionary sale based on negative undisclosed information.
Key Dates
| Date | Description |
|---|---|
| 08/22/2025 | Date of the reported transaction (sale of 7,000 shares of Class A Common Stock). |
| 08/26/2025 | Date the Statement of Changes in Beneficial Ownership (Form 4) was signed by the reporting person's attorney-in-fact. |
Keywords
Dolby Laboratories, DLB, insider trading, stock sale, Form 4, Shriram Revankar, 10b5-1 plan, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.